Skip to content

Checked

Class IIDrug recallTerminated

B-Complex, Thiamine HCI / Riboflavin / Niacinamide / Dexpanthenol / Pyridoxine HCI... recall

Recalled by AnazaoHealth Corporation of Las Vegas, NV · FDA report 01/03/2024

Not an official recall notice and may be delayed. Confirm with the manufacturer or the agency.

Class
Class II
Moderate
Status
Terminated
Closed 09/29/2025
Recall started
11/22/2023
Distribution
Nationwide

Reason for recall

Presence of Particulate Matter.

Class II: Use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.

Recalled product

Product
B-Complex, Thiamine HCI / Riboflavin / Niacinamide / Dexpanthenol / Pyridoxine HCI injection, 74/2/75/2/2 MG/ML, 30ML Sterile Multiple-Dose Vial, Rx only, AnazaoHealth, 7465 W Sunset Rd #1200, Las Vegas, NV 89113, NDC 72682-2230-3
Lot and code info
Lots: 505075, Exp: 02/05/24; 505596, Exp: 02/06/24; 506155, Exp: 02/07/24; 508103, Exp: 02/13/24; 510837, Exp: 02/19/24; 512411, Exp: 02/20/24; 514856, Exp: 02/25/24; 515642, Exp: 02/28/24; 518309, Exp: 03/05/24; 524262, 524266, Exp: 03/12/24; 524909, Exp: 03/13/24; 526526, Exp: 03/16/24; 529204, Exp: 03/18/24; 530858, Exp: 03/20/24; 535766, Exp: 03/30/24
Quantity
5,707 vials
Recall number
D-0203-2024
Event ID
93500
Initiated by
Voluntary: Firm initiated

Where it was distributed

Nationwide in the USA.

  • Nationwide

Recall timeline

  1. 11/22/2023Firm started the recall
  2. 12/26/2023FDA classified it as Class II
  3. 01/03/2024Published in the FDA enforcement report
  4. 09/29/2025FDA closed (terminated) the recall

All products in this recall

2 products under event 93500

More recalls from AnazaoHealth

Frequently asked questions

Why was B-Complex, Thiamine HCI / Riboflavin / Niacinamide / Dexpanthenol / Pyridoxine HCI... recalled?
Presence of Particulate Matter.
What does Class II mean?
Class II is FDA's moderate recall category: use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.
Where was the recalled product sold?
Nationwide in the USA.
Is this recall still active?
The FDA lists the recall as terminated (closed 09/29/2025). FDA has determined the recall is complete and closed it.

Source: U.S. Food and Drug Administration, openFDA enforcement report · Last updated 01/03/2024 · Do not rely on openFDA to make decisions regarding medical care